v3.25.4
Share-based payments (Tables)
12 Months Ended
Dec. 31, 2025
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Disclosure of share-based payment schemes
Charge for the year
2025
2024
2023
£m
£m
£m
Share Value Plan and Deferred Share Value Plan
353
319
284
Others
259
178
191
Total equity settled
612
497
475
Cash settled
40
10
4
Total Share-based payments
652
507
479
Disclosure of share option and award plans The weighted average fair value per award granted, weighted average share price at the date of exercise/release of shares during the year,
weighted average contractual remaining life and number of options and awards outstanding (including those exercisable) at the balance sheet
date were as follows:
2025
2024
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
Weighted
average fair
value per
award
granted in
year
Weighted
average
share price
at exercise/
release
during year
Weighted
average
remaining
contractual
life
Number of
options/
awards
outstanding
£
£
in years
(000s)
£
£
in years
(000s)
SVP and DSVP1,2
2.86
3.09
1
438,402
1.52
1.74
1
504,825
Others1,3
1.46-3.55
3.04-3.99
0-3
210,182
0.81-2.10
1.71-2.12
0-3
240,029
Disclosure of movements in options and awards The movement in the number of options and awards for the major schemes and the weighted average exercise price of options was:
SVP and DSVP1,2
Others1,3
Number (000s)
Number (000s)
Weighted average exercise
price (£)
2025
2024
2025
2024
2025
2024
Outstanding at beginning of year/acquisition date
504,825
495,724
240,029
288,755
1.19
1.06
Granted in the year
144,110
224,385
102,649
132,013
2.99
1.79
Exercised/released in the year
(190,408)
(191,471)
(123,832)
(163,322)
1.01
0.95
Less: forfeited in the year
(20,125)
(23,813)
(7,874)
(15,164)
1.44
1.19
Less: expired in the year
—
—
(790)
(2,253)
1.19
1.25
Outstanding at end of year
438,402
504,825
210,182
240,029
1.54
1.19
Of which exercisable:
—
—
39,755
25,164
0.95
1.23
Notes:
1Options/award granted over Barclays PLC shares.
2Weighted average exercise price is not applicable for SVP and DSVP awards as these are not share option schemes.
3The number of awards within Others at the end of the year principally relates to Sharesave (number of awards exercisable at end of year was 22,046,433 (2024:
5,343,579)). The weighted average exercise price relates to Sharesave.